AmiCOUR IP Group News and Opinions

Transferring Technology:
Purdue OTC Suit Heats Up




Welcome to the AmiCOUR IP Blog.  We invite your comments.  Past Issues.
 

June 2, 2010 - Plaintiff CoMentis, Inc asked a Federal Judge for permission to amend its complaint against Purdue Research Foundation in a dispute which began over terms to license the Foundation's IP. CoMentis has a research focus in chemical compounds and structures which may be potential drug candidates for treating Alzheimer's disease. CoMentis, Inc's Memorandum In Support of Motion to Amend Complaint and Join Party seeks to join Arun K. Ghosh, Ph.D as a defendant and alleges, "After the patent applications were made publicly-available for the first time in mid-April 2010, however, CoMentis learned that its confidential information and intellectual property had been stolen and incorporated by the Proposed Defendants into those patent applications." The Foundation's counsel had previously filed a motion to dismiss the initial November 2009 complaint. Purdue Research Foundation was involved in an unrelated intellectual property dispute in 2004, and Purdue fans were only beginning to forget last year's loss of Naval Research Laboratory funding for cold fusion research.  In April 2010, Foundation  officials named University of Maryland luminary Libby Hart-Wells to take charge of its OTC team. Read comments.